57470-78-7 Usage
Description
Celiprolol hydrochloride, a once-daily, cardioselective β-adrenergic blocker, is a white crystalline solid with chemical properties that make it effective in managing various cardiovascular conditions. It is also being evaluated for its potential use in glaucoma treatment.
Uses
Used in Pharmaceutical Industry:
Celiprolol hydrochloride is used as an antihypertensive agent for the management of hypertension. It helps in reducing high blood pressure by blocking the action of adrenaline on the heart and blood vessels, leading to a decrease in heart rate and blood vessel constriction.
Used in Cardiology:
Celiprolol hydrochloride is used as an antianginal agent for the treatment of angina pectoris, a condition characterized by chest pain due to insufficient blood flow to the heart. It helps in reducing the workload on the heart and the demand for oxygen, thereby alleviating the symptoms of angina.
Used in Cardiology (continued):
Celiprolol hydrochloride is also used as a beta blocker for the management of hyperkinetic heart syndrome, a condition where the heart beats too fast or too forcefully. It helps in regulating the heart rate and reducing the force of heart contractions, thus improving the overall cardiac function.
Used in Ophthalmology (Evaluation):
Celiprolol hydrochloride is being evaluated for its potential use in the treatment of glaucoma, a group of eye diseases that can lead to vision loss. Its cardioselective β-adrenergic blocking properties may offer a novel approach to managing intraocular pressure, a key factor in glaucoma progression.
Brand Names:
Celiprolol hydrochloride is available under the brand names Selecor (Rhone-Poulenc Rorer) and SELECTOL.
Originator
Chemie Linz (Austria)
Clinical Use
#N/A
in vitro
the ability of celiprolol to induce the regulation of beta adrenergic receptors was investigated in s49 lymphoma cells. results showed that celiprolol did not stimulate adenylate cyclase in membranes from wild-type (wt) s49 cells or induced the sequestration of beta adrenergic receptors on intact cells. moreover, exposure of wt s49 cells to celiprolol led to the loss of around half of the total cellular beta adrenergic receptors [1].
in vivo
in a previous study, japanese white rabbits underwent 30 min of ischemia and 48 h of reperfusion. celiprolol was administered 20 min before ischemia with or without pretreatment with n(omega)-nitro-l-arginine methylester (l-name) or 5-hydroxydecanoic acid sodium salt (5-hd). results showed that celiprolol could significantly reduce the infarct size dose-dependently. the infarct size-reducing effect of celiprolol was found to be completely blocked by l-name but not by 5-hd. in addition, celiprolol could increase the myocardial interstitial levels of nox and reduce the intensity of myocardium staining [2].
Drug interactions
Potentially hazardous interactions with other drugsAnaesthetics: enhanced hypotensive effect.Analgesics: NSAIDs antagonise hypotensive effect.Anti-arrhythmics: increased risk of myocardial
depression and bradycardia; increased risk of
bradycardia, myocardial depression and AV block
with amiodarone; increased risk of myocardial
depression and bradycardia with flecainideAntidepressants: enhanced hypotensive effect with
MAOIs.Antihypertensives; enhanced hypotensive effect;
increased risk of withdrawal hypertension with
clonidine; increased risk of first dose hypotensive
effect with post-synaptic alpha-blockers such as
prazosin.Antimalarials: increased risk of bradycardia with
mefloquine.Antipsychotics enhanced hypotensive effect with
phenothiazines.Calcium-channel blockers: increased risk of
bradycardia and AV block with diltiazem;
hypotension and heart failure possible with
nifedipine and nisoldipine; asystole, severe
hypotension and heart failure with verapamil.Cytotoxics: possible increased risk of bradycardia
with crizotinib.Diuretics: enhanced hypotensive effect.Fingolimod: possibly increased risk of bradycardia.Moxisylyte: possible severe postural hypotension.Sympathomimetics: severe hypertension with
adrenaline and noradrenaline and possibly with
dobutamine.
Metabolism
Metabolism of celiprolol is minimal and it is mainly
excreted unchanged in the urine (50%) and faeces (50%)
references
[1] reynolds ee, molinoff pb. down regulation of beta adrenergic receptors in s49 lymphoma cells induced by atypical agonists. j pharmacol exp ther. 1986 dec;239(3):654-60.[2] chen, x. ,minatoguchi, s.,arai, m., et al. celiprolol, a selective β1-blocker, reduces the infarct size through production of nitric oxide in a rabbit model of myocardial infarction. circulation journal 71(4), 574-579 (2007).[3] ong kt et al. effect of celiprolol on prevention of cardiovascular events in vascular ehlers-danlos syndrome: a prospective randomised, open, blinded-endpoints trial. lancet. 2010 oct 30;376(9751):1476-84.
Check Digit Verification of cas no
The CAS Registry Mumber 57470-78-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,4,7 and 0 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 57470-78:
(7*5)+(6*7)+(5*4)+(4*7)+(3*0)+(2*7)+(1*8)=147
147 % 10 = 7
So 57470-78-7 is a valid CAS Registry Number.
InChI:InChI=1/C20H33N3O4.ClH/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6;/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26);1H
57470-78-7Relevant articles and documents
An improved synthesis of a b-blocker celiprolol hydrochloride
Ji, Li,Qian, Chao,Chen, Xin-Zhi,Mao, Xiao-Yuan
, p. 640 - 643,4 (2020/07/30)
Celiprolol hydrochloride, a β-blocker drug, has been synthesised from 4-chloronitrobenzene. The route involved hydrolysis of the chloride and acetylation of the phenol, reduction of the nitro group, and acylation of theamine. This was followed by Fries rearrangement of the acetyl group, Williamson etherification with epichlorohydrin, followed by opening of the epoxide ring and salt formation. The overall yield of celipropol was 39.1% on the basis of 4-chloronitrobenzene. The Fries rearrangement was substantially improved. The process is suitable for industrial application because of its convenient and environmentally friendly reaction conditions.